Consort Medical plc (LON:CSRT) Receives Consensus Rating of “Buy” from Brokerages
Shares of Consort Medical plc (LON:CSRT) have earned an average recommendation of “Buy” from the seven brokerages that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is GBX 1,153.17 ($14.94).
CSRT has been the subject of several recent research reports. Stifel Nicolaus reissued a “hold” rating and issued a GBX 1,100 ($14.25) price target on shares of Consort Medical plc in a research report on Thursday, June 15th. Investec restated a “buy” rating and issued a GBX 1,165 ($15.09) target price on shares of Consort Medical plc in a research report on Thursday, June 15th. Numis Securities Ltd began coverage on Consort Medical plc in a report on Tuesday, April 4th. They issued a “hold” rating and a GBX 1,084 ($14.04) price target for the company. Shore Capital reissued a “buy” rating on shares of Consort Medical plc in a research note on Thursday, March 30th. Finally, N+1 Singer restated a “buy” rating and set a GBX 1,125 ($14.57) price target on shares of Consort Medical plc in a research report on Thursday, June 15th.
WARNING: “Consort Medical plc (LON:CSRT) Receives Consensus Rating of “Buy” from Brokerages” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.americanbankingnews.com/2017/07/14/consort-medical-plc-loncsrt-receives-consensus-rating-of-buy-from-brokerages.html.
Shares of Consort Medical plc (CSRT) traded up 0.48% during trading on Friday, hitting GBX 1040.00. 2,416 shares of the stock traded hands. The stock has a 50 day moving average price of GBX 1,045.24 and a 200-day moving average price of GBX 1,029.71. Consort Medical plc has a 1-year low of GBX 960.00 and a 1-year high of GBX 1,180.00. The stock’s market cap is GBX 514.88 million.
The business also recently announced a dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, September 21st will be paid a dividend of GBX 13.21 ($0.17) per share. The ex-dividend date is Thursday, September 21st. This represents a dividend yield of 1.3%. This is a positive change from Consort Medical plc’s previous dividend of $7.09.
In related news, insider Paul Hayes acquired 4,000 shares of the company’s stock in a transaction dated Tuesday, June 20th. The shares were bought at an average price of GBX 1,094 ($14.17) per share, for a total transaction of £43,760 ($56,683.94).
Consort Medical plc Company Profile
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.
Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.